Cluster of Excellence Precision Medicine in Chronic Inflammation (PMI)

About the Cluster

More and more people in industrial nations are suffering from chronic inflammatory diseases such as Crohn’s disease, psoriasis, diabetes and rheumatism. In the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (PMI), scientists from various medical disciplines and fundamental research are working together on an interdisciplinary basis to significantly improve the diagnosis, treatment and prevention of these diseases. Their vision is to achieve complete control over the diseases – at every stage and as early as possible.

More about the Cluster of Excellence Precision Medicine in Chromic Inflammation (PMI)

 

Why precision medicine?

Preview

Please note: Once you watch the video, data will be transmitted to Youtube/Google. For more information, see Google Privacy.

Cluster news

group photo

DFG Research Unit "miTarget" at Kiel University enters second funding phase

The German Research Foundation (DFG) is funding the Research Unit 5042 "miTarget: The microbiome as a therapeutic target in chronic inflammatory bowel diseases" for a further four years.

 
Röhrchen mit Blut in einem Metallständer

Possible new biomarker for better detection of numerous inflammatory diseases

Increased consumption of tryptophan can indicate minimal residual inflammation in a variety of chronic inflammatory diseases.

 

Young Scientist Retreat 2024

Around 60 young researchers from the Cluster of Excellence PMI met on March 13 and 14, 2024 for a scientific exchange at the Maritim Seehotel on Timmendorfer Strand.

 

Prof. Hundt elected to the board of the Arbeitsgemeinschaft Dermatologische Forschung

Jennifer Hundt from the University of Lübeck was elected to the board for the next four years at the conference of the Arbeitsgemeinschaft Dermatologische Forschung.